The UK Medications and Healthcare Products Regulatory Agency (MHRA) has completed a safety review of topiramate, evaluating possible harm in the learning and development of children whose mothers took topiramate during pregnancy.
The details of their advice and a new Pregnancy Prevention Programme for topiramate users is now published on the MRHA website.
If you have concerns about your use of topiramate in the light of this development, please talk to your prescribing physician.